Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bioventus Inc. - Class A Common Stock
(NQ:
BVS
)
14.09
+0.07 (+0.50%)
Streaming Delayed Price
Updated: 11:26 AM EDT, Sep 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
91,697
Open
13.95
Bid (Size)
14.08 (100)
Ask (Size)
14.10 (500)
Prev. Close
14.02
Today's Range
13.78 - 14.09
52wk Range
6.370 - 15.89
Shares Outstanding
10
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bioventus (BVS) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Pain Treatments surged 11.5% as management explores strategic alternatives.
Via
The Motley Fool
Topics
Earnings
Bioventus Q2 Earnings Call Highlights
↗
August 05, 2026
Bioventus (NASDAQ:BVS) reported second-quarter 2026 revenue growth of 4% and reiterated its full-year financial outlook, citing double-digit expansion in its Pain Treatments business, continued debt...
Via
MarketBeat
Topics
Earnings
Performance
YTD
+95.4%
+95.4%
1 Month
+3.2%
+3.2%
3 Month
+44.1%
+44.1%
6 Month
+57.3%
+57.3%
1 Year
+112.8%
+112.8%
More News
Read More
Bioventus (NASDAQ:BVS) Falls After Q2 Revenue Miss, Launches Strategic Review
↗
August 05, 2026
Via
Chartmill
Bioventus Reports Second Quarter Financial Results
August 05, 2026
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Inc (NASDAQ:BVS) Smashes Q1 Estimates and Lifts Guidance, Shares Rally
↗
May 06, 2026
Via
Chartmill
Bioventus Inc (NASDAQ:BVS) Reports Q4 Earnings Beat and Strong 2026 Outlook
↗
March 05, 2026
Via
Chartmill
Topics
Earnings
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
July 29, 2026
From
Bioventus, Inc.
Via
GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session.
↗
July 02, 2026
Via
Chartmill
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls
↗
June 08, 2026
Via
MarketBeat
Topics
Initial Public Offering
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
June 02, 2026
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus (BVS) Q1 2026 Earnings Transcript
↗
May 06, 2026
Via
The Motley Fool
Topics
World Trade
Bioventus Reports First Quarter Financial Results
May 06, 2026
From
Bioventus, Inc.
Via
GlobeNewswire
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
April 30, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
April 28, 2026
From
Bioventus, Inc.
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Tuesday?
↗
April 14, 2026
Via
Chartmill
Bioventus (BVS) Q4 2025 Earnings Call Transcript
↗
March 05, 2026
Via
The Motley Fool
Topics
Earnings
World Trade
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
February 24, 2026
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
These stocks are gapping in today's session
↗
November 04, 2025
Via
Chartmill
Bioventus Inc (NASDAQ:BVS) Reports Q3 2025 Earnings Beat and Strong Profitability Growth
↗
November 04, 2025
Via
Chartmill
Topics
Earnings
Bioventus Reports Third Quarter Financial Results
November 04, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
October 28, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Bioventus Inc. - Class A Common Stock publicly traded?
Yes, Bioventus Inc. - Class A Common Stock is publicly traded.
What exchange does Bioventus Inc. - Class A Common Stock trade on?
Bioventus Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bioventus Inc. - Class A Common Stock?
The ticker symbol for Bioventus Inc. - Class A Common Stock is BVS on the Nasdaq Stock Market
What is the current price of Bioventus Inc. - Class A Common Stock?
The current price of Bioventus Inc. - Class A Common Stock is 14.09
When was Bioventus Inc. - Class A Common Stock last traded?
The last trade of Bioventus Inc. - Class A Common Stock was at 09/29/26 11:26 AM ET
What is the market capitalization of Bioventus Inc. - Class A Common Stock?
The market capitalization of Bioventus Inc. - Class A Common Stock is 140.90
How many shares of Bioventus Inc. - Class A Common Stock are outstanding?
Bioventus Inc. - Class A Common Stock has 141 shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
